CytoMed Therapeutics Limited (GDTC)

NASDAQ

$0.85

$+0.01

(+1.32%)

After-Hours

CytoMed Therapeutics Limited (GDTC) Live Price Chart

Last updated: ⁦2026-10-13 22:26:00⁩. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.

Summary

CytoMed Therapeutics Limited (GDTC) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $0.85, with a market capitalisation of $10.62M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.68 to $3.68. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$10.62M
Open	$0.84
Day's High	$9.25
Day's Low	$0.68
Previous Close	$0.81
Volume	23.86K
Average Volume	80.50K
P/E Ratio	--
52-Week High	$3.68
52-Week Low	$0.68
Dividend Yield	--
Earnings Date	--

CytoMed Therapeutics Limited (GDTC) After-Hours Stock Price

CytoMed Therapeutics Limited (GDTC) is trading at $0.85 in after-hours trading as of 2026-10-13 20:08:00, up 4.26% ($0.03) from the regular-session close of $0.81.

After-hours trading shows how investors are pricing GDTC after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.

CytoMed Therapeutics Limited (GDTC) 7-Day Stock Price Change

Over the past seven days, CytoMed Therapeutics Limited (GDTC) moved from $0.92 to $0.85, representing a decline of 8.04% ($0.07).

The stock traded between $0.71 and $1.06 during the period. The latest price is near the middle of the 7-day range, indicating strong downward.

The average daily volume was 32.23 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

GDTC 52-Week Price Position

Position in Range: 5.5%

52W Low$0.68

52W High$3.68

GDTC is currently trading at $0.85, placing it 5.5% of the way from its 52-week low of $0.68 to its 52-week high of $3.68. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is CytoMed Therapeutics Limited (GDTC)?

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

CytoMed Therapeutics Limited Information

Employees	42
Exchange	NASDAQ
Company Website	https://w2.cytomed.sg

How to Buy CytoMed Therapeutics Limited (GDTC) Stock on MEXC

Eligible investors can buy real shares of CytoMed Therapeutics Limited (GDTC) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for GDTC and Place Your Order

Open the RealStocks trading page and search for GDTC. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is CytoMed Therapeutics Limited (GDTC) stock price today?

CytoMed Therapeutics Limited (GDTC) is currently trading at $ 0.85, up 4.26% ($0.03) from the previous close of $ 0.81. Intraday prices update in real time during regular trading hours.

2.Is GDTC stock going up or down today?

As of 2026-10-13 20:08:00, GDTC is trading at $ 0.85, up 4.26% ($0.03) from its previous close of $ 0.81. The stock has traded between $ 0.68 and $ 9.25 during today’s regular session. Past price movements do not guarantee future results.

3.What is GDTC pre-market price?

As of 2026-10-13 20:08:00, GDTC is trading at $ 0.84 in pre-market trading, up 2.91% ($0.02) from the previous close of $ 0.81. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is GDTC after-hours price?

As of 2026-10-13 20:08:00, GDTC is trading at $ 0.85 in after-hours trading, up 4.26% ($0.03) from the regular-session close of $ 0.81. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is GDTC stock trading now?

GDTC trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does GDTC sit relative to its 52-week high and low?

Over the past 52 weeks, GDTC has traded between a low of $ 0.68 and a high of $ 3.68. At $ 0.85, the stock is positioned 5.5% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is CytoMed Therapeutics Limited in?

CytoMed Therapeutics Limited (GDTC) operates in the -- sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is CytoMed Therapeutics Limited's market capitalisation and where is it listed?

CytoMed Therapeutics Limited is listed on the NASDAQ exchange with a market capitalisation of $ 10.62M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is GDTC valued in terms of P/E ratio and EPS?

GDTC trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does CytoMed Therapeutics Limited pay a dividend?

CytoMed Therapeutics Limited pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.